Abzena is a provider of services and technologies for the development and manufacture of biopharmaceutical products, serving clients in North America, Europe, and beyond. The company specializes in various areas, including antibody drug conjugates (ADCs), protein engineering, and immunogenicity assessment. Its offerings encompass a range of solutions for antibody discovery and development, including phage display, hybridoma sequencing, and custom assays. Additionally, Abzena provides contract manufacturing services for biopharmaceuticals, such as monoclonal antibodies and recombinant proteins, as well as capabilities for peptide synthesis and bioconjugates. The company supports biopharmaceutical firms and academic institutions, enabling them to advance their drug candidates through innovative technologies like ThioBridge for ADC development. Headquartered in Cambridge, UK, Abzena was incorporated in 2014 and has established a global customer base, including many of the top biopharmaceutical companies.
PacificGMP Inc. is a contract manufacturing organization, engages in developing and manufacturing biologics. It produces monoclonal antibodies, recombinant proteins, vaccine products, insect cell/baculovirus, anchorage and suspension cells, and gene therapy products.
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
Antitope Ltd is a biotechnology research company, develops non-immunogenic protein therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.